missing translation for 'onlineSavingsMsg'
Learn More
Learn More
StAR-related lipid transfer (START) domain containing 4, Mouse, MaxPab™ Polyclonal Antibody, Abnova™
Mouse polyclonal antibody raised against a full-length human STARD4 protein.
Brand: Abnova H00134429-B01.50uL
This item is not returnable.
View return policy
Description
Cholesterol homeostasis is regulated, at least in part, by sterol regulatory element (SRE)-binding proteins (e.g., SREBP1; MIM 184756) and by liver X receptors (e.g., LXRA; MIM 602423). Upon sterol depletion, LXRs are inactive and SREBPs are cleaved, after which they bind promoter SREs and activate genes involved in cholesterol biosynthesis and uptake. Sterol transport is mediated by vesicles or by soluble protein carriers, such as steroidogenic acute regulatory protein (STAR; MIM 600617). STAR is homologous to a family of proteins containing a 200- to 210-amino acid STAR-related lipid transfer (START) domain, including STARD4 (Soccio et al., 2002 [PubMed 12011452]).[supplied by OMIM
Sequence: MEGLSDVASFATKLKNTLIQYHSIEEDKWRVAKKTKDVTVWRKPSEEFNGYLYKAQGVIDDLVYSIIDHIRPGPCRLDWDSLMTSLDILENFEENCCVMRYTTAGQLWNIISPREFVDFSYTVGYKEGLLSCGISLDWDEKRPEFVRGYNHPCGWFCVPLKDNPNQSLLTGYIQTDLRGMIPQSAVDTAMASTLTNFYGDLRKALSpecifications
| StAR-related lipid transfer (START) domain containing 4 | |
| Polyclonal | |
| Mouse polyclonal antibody raised against a full-length human STARD4 protein. | |
| STARD4 | |
| STARD4 | |
| STARD4 (NP_631903.1, 1 a.a. ∼ 205 a.a) full-length human protein. | |
| RUO | |
| 134429 | |
| Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
| Western Blot | |
| Unconjugated | |
| No additive | |
| NM_139164 | |
| Mouse | |
| 50 μL | |
| Primary | |
| Human | |
| Serum |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?